Latest Insider Transactions at C4 Therapeutics, Inc. (CCCC)
This section provides a real-time view of insider transactions for C4 Therapeutics, Inc. (CCCC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of C4 Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of C4 Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2021
|
Malcolm Salter Director |
SELL
Open market or private sale
|
Direct |
755
-6.06%
|
$30,200
$40.11 P/Share
|
|
Oct 15
2021
|
Malcolm Salter Director |
SELL
Open market or private sale
|
Direct |
755
-5.71%
|
$33,220
$44.94 P/Share
|
|
Oct 08
2021
|
Adam Crystal Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+50.0%
|
$60,000
$6.49 P/Share
|
|
Oct 04
2021
|
Kenneth Carl Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
194
+0.23%
|
$8,536
$44.99 P/Share
|
|
Oct 04
2021
|
Alain J Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
222
+50.0%
|
$9,768
$44.99 P/Share
|
|
Oct 04
2021
|
Marc A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
461
+50.0%
|
$20,284
$44.99 P/Share
|
|
Oct 04
2021
|
Glenn Dubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
138
+31.87%
|
$6,072
$44.99 P/Share
|
|
Oct 04
2021
|
Malcolm Salter Director |
BUY
Grant, award, or other acquisition
|
Direct |
300
+2.22%
|
$13,200
$44.99 P/Share
|
|
Oct 01
2021
|
Adam Crystal Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-57.65%
|
$675,000
$45.19 P/Share
|
|
Oct 01
2021
|
Adam Crystal Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$60,000
$4.98 P/Share
|
|
Sep 27
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
1,850
-0.97%
|
$92,500
$50.04 P/Share
|
|
Sep 24
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
3,015
-1.57%
|
$150,750
$50.11 P/Share
|
|
Sep 23
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
19,180
-4.7%
|
$959,000
$50.72 P/Share
|
|
Sep 22
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
10,548
-4.78%
|
$527,400
$50.09 P/Share
|
|
Sep 21
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
10,321
-5.69%
|
$516,050
$50.14 P/Share
|
|
Sep 17
2021
|
Malcolm Salter Director |
SELL
Open market or private sale
|
Direct |
755
-5.52%
|
$36,995
$49.89 P/Share
|
|
Sep 17
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
10,840
-5.37%
|
$542,000
$50.05 P/Share
|
|
Sep 16
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
26,499
-1.84%
|
$1,298,451
$49.55 P/Share
|
|
Sep 15
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
54,193
-20.02%
|
$2,601,264
$48.84 P/Share
|
|
Sep 14
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
984
-0.33%
|
$49,200
$50.02 P/Share
|
|
Sep 13
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
6,660
-2.19%
|
$333,000
$50.07 P/Share
|
|
Sep 10
2021
|
Jolie Siegel Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
12,500
-100.0%
|
$625,000
$50.0 P/Share
|
|
Sep 10
2021
|
Jolie Siegel Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+50.0%
|
$50,000
$4.98 P/Share
|
|
Sep 10
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
2,550
-0.81%
|
$127,500
$50.0 P/Share
|
|
Aug 20
2021
|
Malcolm Salter Director |
SELL
Open market or private sale
|
Direct |
755
-5.23%
|
$30,200
$40.73 P/Share
|
|
Aug 03
2021
|
Stewart Fisher Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
17,057
-42.86%
|
$767,565
$45.01 P/Share
|
|
Aug 03
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
14,407
-13.99%
|
$648,315
$45.16 P/Share
|
|
Aug 02
2021
|
Stewart Fisher Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
18,104
-31.27%
|
$814,680
$45.0 P/Share
|
|
Aug 02
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
4,257
-3.97%
|
$191,565
$45.01 P/Share
|
|
Jul 29
2021
|
Adam Crystal Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-100.0%
|
$675,000
$45.0 P/Share
|
|
Jul 29
2021
|
Adam Crystal Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$60,000
$4.98 P/Share
|
|
Jul 29
2021
|
Stewart Fisher Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
50,211
-46.44%
|
$2,259,495
$45.0 P/Share
|
|
Jul 29
2021
|
Elena Prokupets Director |
SELL
Open market or private sale
|
Indirect |
11,336
-9.56%
|
$510,120
$45.0 P/Share
|
|
Jul 29
2021
|
Jolie Siegel Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
12,500
-100.0%
|
$562,500
$45.0 P/Share
|
|
Jul 29
2021
|
Jolie Siegel Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+50.0%
|
$50,000
$4.98 P/Share
|
|
Jul 16
2021
|
Malcolm Salter Director |
SELL
Open market or private sale
|
Direct |
755
-4.97%
|
$27,935
$37.37 P/Share
|
|
Jul 02
2021
|
Glenn Dubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
157
+50.0%
|
$6,123
$39.72 P/Share
|
|
Jul 02
2021
|
Malcolm Salter Director |
BUY
Grant, award, or other acquisition
|
Direct |
339
+2.18%
|
$13,221
$39.72 P/Share
|
|
Jul 02
2021
|
Kenneth Carl Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
220
+0.26%
|
$8,580
$39.72 P/Share
|
|
Jul 02
2021
|
Alain J Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
251
+32.68%
|
$9,789
$39.72 P/Share
|
|
Jul 02
2021
|
Marc A Cohen Director |
BUY
Grant, award, or other acquisition
|
Direct |
522
+7.29%
|
$20,358
$39.72 P/Share
|
|
Jul 01
2021
|
Adam Crystal Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,000
-94.33%
|
$570,000
$38.16 P/Share
|
|
Jul 01
2021
|
Adam Crystal Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$90,000
$6.5 P/Share
|
|
Jun 18
2021
|
Malcolm Salter Director |
SELL
Open market or private sale
|
Direct |
755
-4.84%
|
$27,935
$37.19 P/Share
|
|
Jun 14
2021
|
Alain J Cohen Director |
BUY
Other acquisition or disposition
|
Indirect |
22,598
+1.28%
|
-
|
|
Jun 14
2021
|
Alain J Cohen Director |
BUY
Other acquisition or disposition
|
Direct |
61,877
+49.89%
|
-
|
|
Jun 14
2021
|
Marc A Cohen Director |
BUY
Other acquisition or disposition
|
Indirect |
22,598
+1.19%
|
-
|
|
Jun 14
2021
|
Marc A Cohen Director |
BUY
Other acquisition or disposition
|
Direct |
92,817
+48.4%
|
-
|
|
May 21
2021
|
Malcolm Salter Director |
SELL
Open market or private sale
|
Direct |
755
-4.62%
|
$27,935
$37.12 P/Share
|
|
Apr 14
2021
|
Kenneth Carl Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
711
+0.42%
|
$2,133
$3.55 P/Share
|